ORMP EPS Estimates
Oramed Pharmaceuticals Inc.
$4.20
-$0.17(-3.89%)
49
Overall
80
Value
20
Tech
47
Quality
Market Cap
$181.78M
Volume
166.46K
52W Range
$2.09 - $5.47
Target Price
$7.00
ORMP EPS estimates: the consensus estimate for Oramed Pharmaceuticals Inc.'s current fiscal year is $1.47 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ORMP EPS Estimates
- EPS estimate, current quarter
- $0.43
- EPS estimate, next quarter
- $0.37
- EPS estimate, current year
- $1.47
- EPS growth, 3-year
- +17.63%
| Fiscal year | EPS |
|---|---|
| 2025 | $1.53 |
| 2024 | $-0.48 |
| 2023 | $0.14 |
| 2022 | $0.94 |
| 2021 | $0.78 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ORMP | $4.20 | -3.9% | 166.46K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Oramed Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW